Reckitt Benckiser Group (LON:RKT) Announces Quarterly Earnings Results

Reckitt Benckiser Group (LON:RKT) posted its earnings results on Wednesday. The company reported GBX 101.40 earnings per share for the quarter, Digital Look Earnings reports. Reckitt Benckiser Group had a return on equity of 45.27% and a net margin of 22.40%.

Here are the key takeaways from Reckitt Benckiser Group’s conference call:

• Q2 growth accelerated significantly, with Core Reckitt like-for-like revenue up 4.2% and volume growth reaching 2%, supported by balanced volume and price/mix contributions across all areas and categories.
• Emerging markets remained a key growth engine, delivering 9.4% like-for-like growth in Q2 and 12 consecutive quarters of double-digit growth in China, led by Dettol, VMS and continued innovation.
• Management reiterated 2026 guidance for 4%–5% Core Reckitt revenue growth and a 24.9%–25.6% adjusted operating margin, expecting stronger second-half performance from pricing, innovation, geographic mix and a more normal seasonal OTC cycle.
• Profitability remained under pressure: Core Reckitt and Mead Johnson gross margin fell 50 basis points to 60.5%, while adjusted EPS declined 9.7% to £1.521, primarily due to higher input costs and the loss of Essential Home earnings.
• Reckitt announced a further £500 million share buyback and increased its interim dividend by 5%, taking shareholder returns since the 2024 strategic plan announcement to more than £6 billion.

Reckitt Benckiser Group Stock Performance

Shares of Reckitt Benckiser Group stock traded up GBX 232 during trading on Wednesday, reaching GBX 5,408. The company’s stock had a trading volume of 69,664,383 shares, compared to its average volume of 24,193,105. The company has a debt-to-equity ratio of 108.83, a quick ratio of 0.46 and a current ratio of 0.85. The business’s fifty day moving average price is GBX 4,809.71 and its 200-day moving average price is GBX 5,289.51. The firm has a market cap of £34.34 billion, a price-to-earnings ratio of 11.11, a price-to-earnings-growth ratio of 1.10 and a beta of 0.25. Reckitt Benckiser Group has a one year low of GBX 3,866 and a one year high of GBX 6,522.92.

Analysts Set New Price Targets

Several research firms have recently issued reports on RKT. Deutsche Bank Aktiengesellschaft decreased their price target on Reckitt Benckiser Group from GBX 5,460 to GBX 5,430 and set a “hold” rating for the company in a research note on Tuesday, April 28th. Royal Bank Of Canada restated a “neutral” rating and issued a GBX 6,200 target price on shares of Reckitt Benckiser Group in a report on Friday, May 15th. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 5,900 target price on shares of Reckitt Benckiser Group in a research report on Wednesday. Citigroup lowered their price target on Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating on the stock in a report on Thursday, April 23rd. Finally, Berenberg Bank dropped their price target on shares of Reckitt Benckiser Group from GBX 7,000 to GBX 6,200 and set a “buy” rating on the stock in a research report on Friday, April 24th. Four research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of GBX 6,247.14.

Insider Buying and Selling

In other Reckitt Benckiser Group news, insider Shannon Eisenhardt bought 432 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The stock was purchased at an average price of £432 per share, for a total transaction of £186,624. Also, insider Marybeth Hays bought 340 shares of the stock in a transaction on Monday, June 1st. The stock was acquired at an average cost of GBX 4,585 per share, for a total transaction of £15,589. In the last 90 days, insiders acquired 1,029 shares of company stock valued at $21,416,350. Insiders own 0.44% of the company’s stock.

Reckitt Benckiser Group Company Profile

At Reckitt, we protect, heal and nurture. We are the company behind some of the world’s best known and most trusted Health and Hygiene consumer brands.

Delivering for a cleaner, healthier world requires strong brands with a global footprint. From Dettol, Lysol, Durex, Finish, Harpic and Vanish, Mucinex, Nurofen, Gaviscon, Veet and Strepsils, consumers love and rely on our brands to care for their families, as they have done for over 200 years.

We use our scientific expertise and deep human understanding to develop solutions to help people improve their lives – that is why over 30 million Reckitt products are sold each day worldwide.

At Reckitt, we’re all making a real difference to people all over the world, every day.